SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Loftus EV Jr., Olivas-Pakzad BA, Batts KP, Adkins MC, Stephens DH, Sarrm MG, et al. Intraductal papillary-mucinous tumors of the pancreas: clinicopathologic features, outcome, and nomenclature. Gastroenterology 1996;110: 190918.
  • 2
    Azar C, Van de Stadt J, Rickaert F, Deviere J, Delhaye M, Baizu M, et al. Intraductal papillary mucinous tumours of the pancreas. Clinical and therapeutic issues in 32 patients. Gut 1996;39: 45764.
  • 3
    World Health Organization. Histological typing of tumours of the exocrine pancreas. In: KloppelG, SolciaE, LongneckerDS, CapellaC, SobinLH, editors. International histological classification of tumours. New York: Springer-Verlag, 1996; 727.
  • 4
    Rivera JA, Fernandez-del Castillo C, Pins M, Compton CC, Lewarndrowski KB, Rattner DW, et al. Pancreatic mucinous ductal ectasia and intraductal papillary neoplasms: a single malignant clinicopathologic entity. Ann Surg 1997; 225: 63746.
  • 5
    Morohoshi T, Kanda M, Asanuma K, Kloppel G. Intraductal papillary neoplasms of the pancreas: a clinicopathologic study of six patients. Cancer 1989; 64: 132935.
  • 6
    Rickaert F, Cremer M, Deviere J, Tavares L, Lambilliotte JP, Schroder S, et al. Intraductal mucin-hypersecreting neoplasms of the pancreas: a clinicopathologic study of eight patients. Gastroenterology 1991; 101: 5129.
  • 7
    Yamada M, Kozuka S, Yamao K, Nakazawa S, Naitoh Y, Tsukamoto Y. Mucin-producing tumor of the pancreas. Cancer 1991; 68: 15968.
  • 8
    Obara T, Maguchi H, Saitoh Y, Ura H, Koike Y, Kitazawa S, et al. Mucin-producing tumor of the pancreas: a unique clinical entity. Am J Gastroenterol 1991; 86: 161925.
  • 9
    Obara T, Saitoh Y, Maguchi H, Ura H, Kitazawa S, Koike Y, et al. Multicentric development of pancreatic intraductal carcinoma through atypical hyperplasia. Hum Pathol 1992; 23: 825.
  • 10
    Fujii T, Obara T, Maguchi H, Tanno S, Ura H, Kohgo Y. Clinicopathologic study of multiple mucin-producing tumors of the pancreas: multicentric development of carcinoma through atypical hyperplasia [in Japanese]. J Jpn Pancreat Soc 1996; 11: 34452.
  • 11
    Inagaki M, Maguchi M, Kino S, Obara M, Ishizaki A, Onodera K, et al. Mucin-producing tumors of the pancreas: clinicopathological features, surgical treatment, and outcome. J Hepatobil Pancreat Surg 1999; 6: 2815.
  • 12
    Fujii H, Inagaki M, Kasai S, Miyokawa N, Tokusashi Y, Gabrielson E, et al. Genetic progression and heterogeneity in intraductal papillary-mucinous neoplasms of the pancreas. Am J Pathol 1997; 151: 144754.
  • 13
    Slaughter DP, Southwick HW, Smejkal W. “Field cancerization” in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer 1953; 6: 9638.
  • 14
    Kanjilal S, Strom SS, Claymon GL, Weber RS, El-Naggar AK, Kapur V, et al. p53 Mutations in nonmelanoma skin cancer of the head and neck: molecular evidence for field cancerization. Cancer Res 1995; 55: 36049.
  • 15
    Ren Z, Hedrum A, Ponten F, Nister M, Ahmadian A, Lundeberg L, et al. Human epidermal cancer and accompanying precursors have identical p53 mutations different from p53 mutations in adjacent areas of clonally expanded non-neoplastic keratinocytes. Oncogene 1996; 12: 76573.
  • 16
    Lydiatt WM, Anderson PE, Bazzana T, Casale M, Hughes CJ, Huvos AG, et al. Molecular support for field cancerization in the head and neck. Cancer 1998; 82: 137680.
  • 17
    Chung KY, Mukhopadhyay T, Kim J, Casson A, Ro JY, Goepfert H, et al. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Res 1993; 53: 167683.
  • 18
    Sozzi G, Miozzo M, Pastorino U, Pilotti S, Donghi R, Giarola M, et al. Genetic evidence for an independent origin of multiple preneoplastic and neoplastic lung lesions. Cancer Res 1995; 55: 13540.
  • 19
    van Oijen MGCT, Leppers vd Straat FG, Tilanus MGJ, Slootweg P. The origins of multiple squamous cell carcinomas in the aerodigestive tract. Cancer 2000; 88: 88493.
  • 20
    Kuukasjarvi T, Karhu R, Tanner M, Kahkonen M, Schaffer A, Nupponen N, et al. Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res 1997; 57: 1597604.
  • 21
    Wang LD, Zhou Q, Hong J, Qiu S, Yang CS. p53 Protein accumulation and gene mutations in multifocal esophageal precancerous lesions from symptom free subjects in a high incidence area for esophageal carcinoma in Henan, China. Cancer 1996; 77: 12449.
  • 22
    Tian D, Feng Z, Hanley NM, Woodrow Setzer R, Mumford JL, DeMarini D. Multifocal accumulation of p53 protein in esophageal carcinoma: evidence for field cancerization. Int J Cancer 1998; 78: 56875.
  • 23
    Sidransky D, Frost P, von Eschenbach A, Oyasu R, Preisinger A, Vogelstein B. Clonal origin of bladder cancer. N Engl J Med 1992; 326: 73740.
  • 24
    Yanagisawa A, Ohtake K, Ohashi K, Hori M, Kitagawa T, Sugano H, et al. Frequent c-Ki-ras oncogene activation in mucinous cell hyperplasia of the pancreas suffering from chronic inflammation. Cancer Res 1993; 53: 95356.
  • 25
    Tada M, Ohashi M, Shiratori Y, Okudaira T, Komatu Y, Kawabe T, et al. Analysis of k-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. Gastroenterology 1996; 110: 22731.
  • 26
    Tada M, Omata M, Ohto M. Ras gene mutations in intraductal papillary neoplasms of the pancreas. Cancer 1991; 67: 6347.
  • 27
    Yanagisawa A, Kato Y, Ohtake K, Kitagawa T, Ohashi K, Hori M, et al. c-Ki-ras point mutations in ductectatic-type mucinous cystic neoplasms of the pancreas. Jpn J Cancer Res 1991; 82: 105660.
  • 28
    Sessa F, Solcia E, Capella C, Bonato M, Scarpa A, Zamboni G, et al. Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and k-ras, p53, and c-erbB-2 abnormalities in 26 patients. Virchows Arch 1994; 425: 35767.
  • 29
    Hoshi T, Imai M, Ogawa K. Frequent k-ras mutations and absence of p53 mutations in mucin-producing tumor of the pancreas. J Surg Oncol 1994; 55: 8491.
  • 30
    Z'graggen K, Rivera JA, Compton CC, Pins M, Werner J, Fernandez-del Castillo C, et al. Prevalence of activating k-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreas. Ann Surg 1997; 226: 491500.
  • 31
    Wainscoat JS, Fey MF. Assessment of clonality in human tumors: a review. Cancer Res 1990; 50: 135560.
  • 32
    Terhune PG, Phifer DM, Tosteson TD, Longnecker DS. K-ras mutation in focal proliferative lesions of human pancreas. Cancer Epidemiol Biomarkers Prev 1998; 7: 51521.
  • 33
    Matsubayashi H, Watanabe H, Yamaguchi T, Ajioka Y, Nishikura K, Iwafuchi M, et al. Multiple K-ras mutations in hyperplasia and carcinoma in cases of human pancreatic carcinoma. Jpn J Cancer Res 1999; 90: 8418.
  • 34
    Losi L, Benhattar J, Costa J. Stability of K-ras mutations throughout the natural history of human colorectal cancer. Eur J Cancer 1992; 28: 111520.
  • 35
    Luttges J, Schlehe B, Menke MAO, Vogel I, Henne-Bruns D, Kloppel G. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium. Cancer 1999; 85: 170310.
  • 36
    Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmount JW. Methylation of Hpa II and Hha I sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 1992; 51: 122939.
  • 37
    Busque L, Gilliland DG. Clonal evolution in acute myeloid leukemia. Blood 1993; 82: 33742.
  • 38
    Willman CL, Busque L, Griffith BB, Favara BE, McClain KL, Duncan MH, et al. Langerhans '—cell histiocytosis (histiocytosis X)—a clonal proliferative disease. N Engl J Med 1994; 331: 15460.
  • 39
    Nomura S, Kaminishi M, Sugiyama K, Oohara T, Esumi H. Clonal analysis of isolated single fundic and pyloric gland of stomach using X-linked polymorphism. Biochem Biophys Res Commun 1996; 226: 38590.
  • 40
    Wu CD, Wickert RS, Williamson JE, Sun NC, Brynes RK, Chan WC. Using fluorescence-based human androgen receptor gene assay to analyze the clonality of microdissected dendritic cell tumors. Am J Clin Pathol 1999; 111: 10510.
  • 41
    Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang, Z, Goldstein SR, et al. Laser capture microdissection. Science 1996; 274: 9981001.
  • 42
    Sirivatanauksorn Y, Sirivatanauksorn V, Bhattacharya S, Davidson BR, Dhillon AP, Kakkar AK, et al. Evolution of genetic abnormalities in hepatocellular carcinomas demonstrated by DNA fingerprinting. J Pathol 1999; 189: 34450.
  • 43
    Levi S, Urbano-Ispizua A, Gill R, Thomas DM, Gilbertson TJ. Foster C, et al. Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res 1991;51: 3497502.
  • 44
    Lyon MF. X-chromosome inactivation and developmental patterns in mammals. Biol Re 1972; 47: 135.
  • 45
    Niho S, Yokose T, Suzuki K, Kodama T, Nishiwaki Y, Mukai K. Monoclonaity of atypical adenomatous hyperplasia of the lung. Am J Pathol 1999; 154: 24954.
  • 46
    Jimbo H, Hitomi Y, Yoshikawa H, Yana T, Momoedera M, Sakamoto A, et al. Evidence for monoclonal expansion of epithelial cells in ovarian endometrial cysts. Am J Pathol 1997; 150: 11738.
  • 47
    Moskaluk CA, Hruban RH, Kern SE. p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. Cancer Res 1997; 57: 21403.
  • 48
    Wilentz RE, Geradts J, Maynard R, Offerhaus GJA, Kang M, Goggins M, et al. Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression. Cancer Res 1998; 58: 47404.
  • 49
    Luttges J, Reinecke-Luthge A, Mollmann B, Menke MAOH, Clemens A, Klimpfinger M, et al. Duct changes and K-ras mutations in the disease-free pancreas: analysis of type, age, relation and spatial distribution. Virchows Arch 1999; 435: 4618.
  • 50
    Motojima K, Urano T, Nagata Y, Shiku H, Tsurifune T, Kanematsu T. Detection of point mutations in the Kirsten-ras oncogene provides evidence for the multicentricity of pancreatic carcinoma. Ann Surg 1993; 217: 13843.
  • 51
    Chari S, Raimond M, Clain JE, Norton ID, Pearson RK, Petersen BT, et al. Is benign pancreatic intraductal papillary-mucinous tumor (IPMT) truly benign? Gastroenterology 2000; 118(Suppl 2): A642.
  • 52
    Novelli MR, Williamson JA, Tomlinson IPM, Elia G, Hodgson SV, Talbot IC, et al. Polyclonal origin of colonic adenomas in an XO/XY patients with FAP. Science 1996; 272: 118790.
  • 53
    Perren A, Roth J, Mulleta-Feurer S, Saremaslani P, Speel EJM, Heitz PU, et al. Clonal analysis of sporadic pancreatic endocrine tumors. J Pathol 1998; 186: 36371.
  • 54
    Noguchi S, Motomura K, Inaji H, Imaoka S, Koyama H. Clonal analysis of fibroadenoma and phyllodes tumor of the breast by means of polymerase chain reaction. Cancer Res 1993; 53: 40714.
  • 55
    Farber E. Monoclonal and polyclonal development of digestive tract tumors in chimeric mice. Jpn J Cancer Res 1997; 88: 245.
  • 56
    Garcia SB, Park HS, Novelli M, Wright NA. Field cancerization, clonality, and epithelial stem cells: the spread of mutated clones in epithelial sheets. J Pathol 1999; 187: 6181.
  • 57
    Enomoto T, Fujita M, Inoue M, Tanizawa O, Nomura T, Shroyer KR. Analysis of clonality by amplification of short tandem repeats. Diag Mol Pathol 1994; 3: 2927.